Indian drugmaker Dr Reddy's Laboratories hopes to launch two-to-three generic products in the United States this year in a bid to increase its share of a lucrative market, its chief executive said.
.jpg)
Global pharmaceutical firms have had a series of patent disputes with Indian makers of generic drugs and several recent Indian rulings have gone against the international giants.
Generic drugmakers cannot be sued under state law for adverse reactions to their products.
Indian drugmaker Ranbaxy Laboratories Ltd has received approval from the US Food and Drug Administration to market an oral suspension form of Warner Chilcott's Duricef antibiotic, the Bombay Stock Exchange
Drugmaker Dr Reddy's Laboratories has filed an application with the US Food and Drug Administration to market a generic form of Eli Lilly's schizophrenia drug Olanzapine in the US
Wockhardt said, the drug regulator suspended the manufacture, sale or distribution of fixed dose combination of Dicyclomine Hydrochloride IP 10mg
Netmed plans to procure from drug manufacturers and sell to pharmacies it has tie-ups with, and to spread its network to all tier-II and tier-III cities.
Overall slowdown in the economy and growing volumes of unbranded generic medicines in the domestic market are behind poor sales.
Market breadth depicted strength. There were almost 3 gainers against every loser on BSE
From Ranbaxy to Religare, Aashish Aryan takes you through a maze of legal cases involving Malvinder Mohan Singh and his younger brother Shivinder Mohan Singh. Both are in police custody following a complaint of fund siphoning.
Sun gets RBI nod for transfer of Ranbaxy overseas investments.
The company did not comply to the 'good manufacturing practice' norms.
It could also ease the burden on the 225 million women in developing countries, says Ari Altstedter.
Under terms of the agreed deal, Ranbaxy shareholders will get 0.8 of a Sun Pharmaceutical share for each Ranbaxy share they own.
Two individuals filed the petition in the high court of Andhra Pradesh
Company aims to build five Rs 100 cr-plus brands and launch products from South African arm in domestic market
Few drugs in the market are not approved by the authorities and can be life-threatening.
Food and Drug Authority Ghana said in a statement that officials of Bliss GVS Pharma of India and Ghanaian drug maker Tobinco Pharmaceuticals have apologised to it for importing 'fake malaria medicine' to Ghana to treat malaria in children.
TCS created wealth worth Rs 3,458 billion for the period 2010-15.
Drug major Novartis has been slapped with a Rs 300-crore penalty by drug regulator NPPA for overcharging consumers on sale of Voveran, its best-selling painkiller medicine.
Sun Pharma open to large acquisitions post Ranbaxy.
Ranbaxy, which is 63.5 per cent-owned by Japan's Daiichi Sankyo Co and gets more than 40 per cent of its sales from the United States, did not immediately respond to a request on Wednesday for comment on the FDA observations.
FDA had cancelled Ranbaxy's approvals to launch generic Nexium, Valcyte
Drugs under exemption make up roughly 95 per cent of the antiretrovirals used by India's AIDS patients
Western drugmakers, including Pfizer Inc, Novartis AG, Roche Holding AG and Sanofi SA, covet a bigger share of the fast-growing Indian drugs market.
Ties between India and the United States have been strained in recent years because of trade policies and patent disputes.
In addition, the CPSC asserted that the company violated the CPSA by failing to immediately advise the CPSC of the alleged violations.
Almost a year after announcing a $4 billion deal, Sun Pharmaceutical Industries on Tuesday said merger of Ranbaxy with itself has been 'consummated.'
.jpg)
The British drugmaker said the shot, called RTS,S, is intended exclusively for use outside the European Union but will be evaluated by the European Medicines Agency in collaboration with the World Health Organisation.
Relaxing FDI norms will provide a major impetus to employment and job creation.
The fees for facility inspection of foreign companies have been reduced
Traders are closely watching the progress of the monsoon.
Sun Pharma was by far the biggest gainer in the Sensex pack, surging 8.13 per cent, followed by Dr Reddy's at 4.92 per cent.
The French drug maker has its vaccine approved in Mexico for all four serotypes for patients aged 9 to 45.
In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.
Bank shares were the top losers along with index heavyweight RIL
Indian companies have raised $1 billion so far this year - almost four times what they raised last year.
According to Munjal, there is an opportunity for somebody who comes from a not for profit background in health care to do something.
Zika virus outbreak in Brazil does not pose enough of a threat to warrant cancelling or putting off the Olympic Games set to be held in Rio de Janeiro in August, a leading US health official said.
The comments need to be submitted to the Competition Commission of India within 15 days, along with supporting documents on how the merger can adversely impact the concerned person or entity, the regulator said, while adding that it would not consider 'unsubstantiated objections' to the deal.
